Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
about
Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertensionThe limits of oral therapy in pulmonary arterial hypertension managementInterdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologistsDrug treatment of pulmonary hypertension in childrenFrontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasiaBiomarkers for pediatric pulmonary arterial hypertension - a call to collaboratePulmonary arterial hypertension associated with congenital heart disease and Eisenmenger syndrome: current practice in pediatricsPulmonary Arterial Hypertension and the Sex Hormone Paradox.Pulmonary Hypertension in Children.Persistent Challenges in Pediatric Pulmonary Hypertension.A pilot study of the effect of spironolactone therapy on exercise capacity and endothelial dysfunction in pulmonary arterial hypertension: study protocol for a randomized controlled trial.Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry.Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients.Pediatric pulmonary arterial hypertension.Change in Pediatric Functional Classification During Treatment and Morbidity and Mortality in Children with Pulmonary HypertensionPulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric populationAddressing the challenges of phenotyping pediatric pulmonary vascular diseaseFrom short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertensionSafety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertensionSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension in children.Progress in the diagnosis and management of pulmonary hypertension in children.Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertensionComparison between the Acute Pulmonary Vascular Effects of Oxygen with Nitric Oxide and Sildenafil.Pulmonary Arterial Hypertension among HIV-Infected Children: Results of a National Survey and Review of the LiteratureTrends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.Advances in pediatric pulmonary arterial hypertension.Hospitalizations of Children With Pulmonary Hypertension: Implications for Improving Care.Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension.Predictors of Catastrophic Adverse Outcomes in Children With Pulmonary Hypertension Undergoing Cardiac Catheterization: A Multi-Institutional Analysis From the Pediatric Health Information Systems Database.Epidemiology and clinical management of pulmonary hypertension in children.Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children.Circulating cytokines and growth factors in pediatric pulmonary hypertensionHemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension.Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces.Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children? - a prospective randomized study.Deformation pattern and predictive value of right ventricular longitudinal strain in children with pulmonary arterial hypertension.Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease.
P2860
Q26771505-87AE4FC5-BDCB-458A-9080-91BDC57E209DQ26773209-7ADD46FC-D844-439B-86D9-ED2EC8E13EB5Q26860314-F14E07E2-AAF3-4575-A37F-B8462D20B616Q26996078-5098D878-0C25-49C0-A3B0-5DCE79227FD3Q27025986-8555C770-D399-4E55-9689-45B7DCBD070AQ27026465-30297553-B078-48CA-9D56-9D34B76560CAQ28085572-A42C73E7-6501-4F19-B4CF-BF6E0A44E309Q30241478-E5EF5A31-ACC2-403E-B2A4-560671CC991FQ30248871-DF7EA063-4755-4DA2-8E0C-554EAFF113D2Q30251927-F012BE01-BDB6-4211-8BC1-E25BFB5AA6CBQ30539790-85007A29-F494-408F-8ECA-22ABAD6BED3EQ30868378-3AE88E5A-032D-4EDB-8D95-C1252ADBF100Q30874440-D3654BDE-B278-43F7-A899-CA295CF61334Q33163446-B6610645-89BF-4C27-8AF2-D550CC232A63Q33166789-64267238-AFF5-4F5A-BC89-77B4B61486E7Q33738542-606606A8-9AE4-446F-9FFA-E9667455BE1BQ33738631-033DEAF9-12FA-4F2B-85A7-748DECA81E66Q33806102-24B498DC-028E-49CF-B772-49010DCD182AQ33806197-0201237B-2528-41F8-8E16-BE6AB55EB2DCQ33965872-8E543AEC-A88A-4E5C-95E6-F4149D4FA684Q34479289-33FFA4DB-153F-4053-8F2A-3136E27A9C4BQ35053507-8AEC8B0A-5800-45B8-B90E-0158E2F9CA66Q35140275-E11445A1-B90C-454C-987B-6396F4FF5152Q35296597-A6504024-3DEF-4732-9F13-AE588456E419Q35665767-CF3FFD5D-C2BB-4F91-AEF5-C90A5B58D1BDQ35869437-E941ADB4-F528-48F2-B3F4-22F2929857E6Q35894788-47CE18D2-5CAB-4CB8-BC78-CF8A8716BC69Q36013002-929EA245-DE96-46DF-9913-D3CCC8952BF8Q36053745-51938FC0-8198-4E3A-AFB3-0B75470064F5Q36223055-9262A177-B748-4380-91A2-60C3E57DD70EQ36427718-2439E7C8-162F-4A03-AF8B-320AA4BD8F3CQ36505843-C990C837-AF58-4619-A36E-473BB5D1BA08Q36541797-44A12A80-0500-414C-BF90-D6AD437AD0FFQ36601764-F03DDCD7-279C-45BC-BE47-8A637D008749Q36718346-EB701F85-D288-48BA-9F09-F013E8EA058BQ36734230-F0E9B780-3248-417E-85E1-D618EF67F890Q36810827-BD92DBCE-8718-4F5B-B762-A3C9193C4C8AQ36939530-49BE2597-FBFF-4857-BDF3-630A08DDCAACQ37138898-DA8104FB-F7C4-48FC-AF87-E3948EA3F98AQ37248319-119BCDDA-552E-4CCE-B469-B7074B09296E
P2860
Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Survival in childhood pulmonar ...... pertension disease management.
@ast
Survival in childhood pulmonar ...... pertension disease management.
@en
type
label
Survival in childhood pulmonar ...... pertension disease management.
@ast
Survival in childhood pulmonar ...... pertension disease management.
@en
prefLabel
Survival in childhood pulmonar ...... pertension disease management.
@ast
Survival in childhood pulmonar ...... pertension disease management.
@en
P2093
P1433
P1476
Survival in childhood pulmonar ...... pertension disease management.
@en
P2093
Aimee J Foreman
C Gregory Elliott
D Dunbar Ivy
Dave P Miller
Michael D McGoon
Robyn J Barst
P304
P356
10.1161/CIRCULATIONAHA.111.026591
P407
P577
2011-11-15T00:00:00Z